Trial Profile
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Galderma
- 10 Feb 2014 New trial record